ID CLB HC.PH.BIO.CLB
Develops drugs, biologics or cell and gene therapies with no approved product on the market (no revenue, or milestones only); such a developer is here, not in contract research.
Sector, group and industry above this class, as placed in the current release. The sector and the industry link to their companies.
Companies whose primary class this is. The sector and industry pages and the screener count them the same way.
| Company | Ticker | Country | Market cap | Filings |
|---|---|---|---|---|
| Kiromic Biopharma Inc | KRBP | United States of America | — | 252 |
| AprilBio Co.,Ltd. | 397030 | South Korea | — | 251 |
| TaiRx, Inc. | 6580 | Taiwan | — | 250 |
| HEXIMA LIMITED. | HXL | Australia | — | 249 |
| TheraVet SA | ALVET | Belgium | — | 239 |
| Original BioMedicals Co., Ltd. | 6483 | Taiwan | — | 236 |
| CHA Vaccine Research Institute | 261780 | South Korea | — | 231 |
| TME Pharma N.V. | ALTME | Netherlands | — | 228 |
| ImmuneOnco Biopharmaceuticals (Shanghai) Inc. | 1541 | Hong Kong | — | 224 |
| Lir Life Sciences Corp. | SKNY | Canada | — | 224 |
| Qyuns Therapeutics Co., Ltd. | 2509 | Hong Kong | — | 222 |
| Infant Bacterial Therapeutics | IBT | Sweden | — | 221 |
| Thiogenesis Therapeutics, Corp. | TTI | Canada | — | 220 |
| Moogene Medi Co., Ltd. | 322970 | South Korea | — | 219 |
| Shaperon Inc. | 378800 | South Korea | — | 219 |
| Great Novel Therapeutics Biotech & Medicals | 7427 | Taiwan | — | 217 |
| Holy Stone Healthcare Co., Ltd. | 4194 | Taiwan | — | 217 |
| IRLAB Therapeutics | IRLAB | Sweden | — | 216 |
| Chordia Therapeutics,Inc | 190A | Japan | — | 215 |
| D&D Pharmatech Inc. | 347850 | South Korea | — | 215 |
| SINEW PHARMA INC. | 6634 | Taiwan | — | 211 |
| Ananda Pharma Plc | ANAN | United Kingdom | — | 206 |
| Lukas Biomedical INC. | 6814 | Taiwan | — | 204 |
| HeXun Biosciences Co., Ltd. | 6986 | Taiwan | — | 203 |
| ViGenCell Inc. | 308080 | South Korea | — | 203 |
| Elanix Biotechnologies AG | ELN | Germany | — | 201 |
| CHO PHARMA, INC. | 6586 | Taiwan | — | 196 |
| ProGen, Co,, LTD. | 296160 | South Korea | — | 196 |
| Advagene Biopharma Co., Ltd. | 6709 | Taiwan | — | 194 |
| ZERUN CO., LTD | 301636 | China | — | 192 |
| Gwo Xi Stem Cell Applied Technology Co., Ltd. | 6704 | Taiwan | — | 190 |
| Biophytis | BPTS | United States of America | — | 189 |
| LAUNXP BIOMEDICAL CO., LTD. | 6876 | Taiwan | — | 186 |
| Oncoinvent ASA | OCIN | Norway | — | 182 |
| MapLight Therapeutics, Inc. | MPLT | United States of America | — | 179 |
| TAHO Pharmaceuticals Ltd. | 6467 | Taiwan | — | 179 |
| Y-Biologics, Inc | 338840 | South Korea | — | 177 |
| HEM Pharma Inc. | 376270 | South Korea | — | 174 |
| Onco-Innovations | ONCO | Canada | — | 172 |
| Sharp Therapeutics Corp. | SHRX | Canada | — | 167 |
| Veritas In Silico Inc. | 130A | Japan | — | 166 |
| MegaPro Biomedical Co. Ltd. | — | Malaysia | — | 165 |
| MYND Life Sciences Inc. | MYND | Canada | — | 161 |
| Curocell Inc. | 372320 | South Korea | — | 159 |
| K Pharma,Inc. | 4896 | Japan | — | 159 |
| NeuroThera Labs Inc. | NTLX | Canada | — | 159 |
| Cuorips Inc. | 4894 | Japan | — | 158 |
| Laekna, Inc. | 2105 | Hong Kong | — | 158 |
| Wuhan YZY Biopharma Co., Ltd. | 2496 | Hong Kong | — | 155 |
| LTR PHARMA LIMITED | LTP | Australia | — | 151 |
Other names for this activity, and where neighboring activities go instead.
preclinicaldrug developer
Research-led company whose approved medicines, which it discovered, are in one or two therapeutic areas; it moves to Branded Prescription Drugs only after two consecutive annual reports with approved products in three or more.
https://financialfilings.com/oics/CLB/
This page is keyed by the class ID CLB. IDs are assigned in v0.3 and freeze at v1.0; from then on an ID is never renamed or reused, and if the class moves in the tree, its ID and this URL stay the same.
Sign in or create a free account - no password needed.
By continuing, you agree to our Terms and Privacy Policy.